HSF1 and cancer: HSP90 is often overexpressed in various cancers, including breast and lung cancer, where it significantly contributes to the survival and proliferation of cancer cells by stabilizing oncogenic proteins.638 STA9090, an HSP90 inhibitor, exerts its anti-cancer effects by promoting the degradation of these oncogenic proteins, thereby disrupting their stability and leading to the condensation of HSF1.